Idarucizumab dabigatran antidote: Phase I data

A double-blind, placebo-controlled, crossover, Belgian Phase I trial in 46 healthy volunteers ages 45-80 and patients with mild or moderate kidney impairment treated with the anticoagulant Pradaxa da...